đ¤ AI Summary
Atypical mitosis is a critical histopathological marker for assessing tumor aggressiveness, yet its identification is hindered by inter-domain variations (e.g., staining and scanning equipment differences) and severe class imbalance. To address these challenges, we propose a domain-generalizable robust classification framework. First, we introduce stain-aware augmentationâcombining Macenko stain normalization with joint geometric and intensity augmentationâto mitigate domain shift. Second, we design a weighted sampling strategy coupled with a hybrid loss functionâintegrating weighted binary cross-entropy and focal lossâto jointly tackle label imbalance. The model is built upon DenseNet121 and trained end-to-end. On the MIDOG 2025 test set, our method achieves 85.0% balanced accuracy, 0.927 AUROC, 89.2% sensitivity, and 80.9% specificityâsubstantially outperforming baseline methods. These results demonstrate strong generalization across heterogeneous imaging devices and underscore the clinical applicability of our approach.
đ Abstract
Atypical mitotic figures are important biomarkers of tumor aggressiveness in histopathology, yet reliable recognition remains challenging due to severe class imbalance and variability across imaging domains. We present a DenseNet-121-based framework tailored for atypical mitosis classification in the MIDOG 2025 (Track 2) setting. Our method integrates stain-aware augmentation (Macenko), geometric and intensity transformations, and imbalance-aware learning via weighted sampling with a hybrid objective combining class-weighted binary cross-entropy and focal loss. Trained end-to-end with AdamW and evaluated across multiple independent domains, the model demonstrates strong generalization under scanner and staining shifts, achieving balanced accuracy 85.0%, AUROC 0.927, sensitivity 89.2%, and specificity 80.9% on the official test set. These results indicate that combining DenseNet-121 with stain-aware augmentation and imbalance-adaptive objectives yields a robust, domain-generalizable framework for atypical mitosis classification suitable for real-world computational pathology workflows.